TRCT
TRPX

Tower Research Capital (TRC)’s Therapix Biosciences Ltd. TRPX Stock Holding History

Tower Research Capital (TRC)’s Portfolio TRPX Stock Details TRPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-100
Closed -$1K – 4311
2017
Q2 		$1K Sell
100
-135
-57% -$939 ﹤0.01% 2564
2017
Q1 		$2K Buy
+235
New +$2.07K ﹤0.01% 2713

Other funds holding TRPX

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Tower Research Capital (TRC)'s TRPX Position: Q3 2017 in Review

Tower Research Capital (TRC) sold out of Therapix Biosciences Ltd. (TRPX) in Q3 2017, closing a stake of 100 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in TRPX in Q1 2017 and held it in 2 quarters. The position peaked at $2K in Q1 2017. 6 funds tracked by Wall St. Rank hold TRPX as of Q3 2017.

  • Tower Research Capital (TRC) reported no remaining Therapix Biosciences Ltd. position as of Q3 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 100 Therapix Biosciences Ltd. shares in Q3 2017, an estimated $1K.
  • Tower Research Capital (TRC) first reported a position in Therapix Biosciences Ltd. in Q1 2017 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s Therapix Biosciences Ltd. position peaked at $2K in Q1 2017.
  • 6 funds tracked by Wall St. Rank held Therapix Biosciences Ltd. as of Q3 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.